Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Upgrades
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- For Sealed Air Corp (NYSE:SEE), Seaport Global upgraded the previous rating of Neutral to Buy. Sealed Air earned $0.89 in the fourth quarter, compared to $0.78 in the year-ago quarter. At the moment, the stock has a 52-week-high of $47.90 and a 52-week-low of $17.06. Sealed Air closed at $45.42 at the end of the last trading period.
- For Blackbaud Inc (NASDAQ:BLKB), Benchmark upgraded the previous rating of Hold to Buy. For the fourth quarter, Blackbaud had an EPS of $0.85, compared to year-ago quarter EPS of $0.51. At the moment, the stock has a 52-week-high of $83.70 and a 52-week-low of $38.22. Blackbaud closed at $77.20 at the end of the last trading period.
- According to Gordon Haskett, the prior rating for Nordstrom Inc (NYSE:JWN) was changed from Hold to Buy. Nordstrom earned $0.22 in the third quarter, compared to $0.81 in the year-ago quarter. The stock has a 52-week-high of $42.22 and a 52-week-low of $11.72. At the end of the last trading period, Nordstrom closed at $34.02.
- For Mesa Air Group Inc (NASDAQ:MESA), Deutsche Bank upgraded the previous rating of Hold to Buy. Mesa Air Group earned $0.36 in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $8.64 and a 52-week-low of $2.05. At the end of the last trading period, Mesa Air Group closed at $7.44.
- According to SVB Leerink, the prior rating for Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) was changed from Market Perform to Outperform. For the fourth quarter, Deciphera Pharmaceuticals had an EPS of $1.10, compared to year-ago quarter EPS of $1.31. The current stock performance of Deciphera Pharmaceuticals shows a 52-week-high of $71.11 and a 52-week-low of $33.10. Moreover, at the end of the last trading period, the closing price was at $48.32.
- JP Morgan upgraded the previous rating for Model N Inc (NYSE:MODN) from Underweight to Neutral. In the first quarter, Model N showed an EPS of $0.16, compared to $0.12 from the year-ago quarter. The current stock performance of Model N shows a 52-week-high of $44.56 and a 52-week-low of $15.00. Moreover, at the end of the last trading period, the closing price was at $40.62.
- For The Hain Celestial Group Inc (NASDAQ:HAIN), Piper Sandler upgraded the previous rating of Neutral to Overweight. Hain Celestial Group earned $0.34 in the second quarter, compared to $0.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $45.42 and a 52-week-low of $18.12. Hain Celestial Group closed at $42.34 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
- For Stoke Therapeutics Inc (NASDAQ:STOK), Wedbush downgraded the previous rating of Outperform to Neutral. In the third quarter, Stoke Therapeutics showed an EPS of $0.41, compared to $0.26 from the year-ago quarter. At the moment, the stock has a 52-week-high of $71.58 and a 52-week-low of $15.82. Stoke Therapeutics closed at $66.33 at the end of the last trading period.
- For Masco Corp (NYSE:MAS), Loop Capital downgraded the previous rating of Buy to Hold. For the fourth quarter, Masco had an EPS of $0.75, compared to year-ago quarter EPS of $0.54. The current stock performance of Masco shows a 52-week-high of $60.16 and a 52-week-low of $27.04. Moreover, at the end of the last trading period, the closing price was at $56.32.
- SVB Leerink downgraded the previous rating for Incyte Corp (NASDAQ:INCY) from Market Perform to Underperform. For the fourth quarter, Incyte had an EPS of $0.93, compared to year-ago quarter EPS of $0.65. The stock has a 52-week-high of $110.36 and a 52-week-low of $62.48. At the end of the last trading period, Incyte closed at $89.46.
- For Corvus Pharmaceuticals Inc (NASDAQ:CRVS), Mizuho downgraded the previous rating of Buy to Neutral. Corvus Pharmaceuticals earned $0.33 in the third quarter, compared to $0.37 in the year-ago quarter. The current stock performance of Corvus Pharmaceuticals shows a 52-week-high of $6.88 and a 52-week-low of $1.01. Moreover, at the end of the last trading period, the closing price was at $4.77.
- For Chuy's Holdings Inc (NASDAQ:CHUY), Raymond James downgraded the previous rating of Outperform to Market Perform. For the third quarter, Chuy's Holdings had an EPS of $0.31, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $43.35 and a 52-week-low of $7.28. At the end of the last trading period, Chuy's Holdings closed at $40.49.
- Morgan Stanley downgraded the previous rating for Qualys Inc (NASDAQ:QLYS) from Equal-Weight to Underweight. Qualys earned No EPS Value in the fourth quarter, compared to $0.64 in the year-ago quarter. At the moment, the stock has a 52-week-high of $148.84 and a 52-week-low of $63.37. Qualys closed at $129.78 at the end of the last trading period.
- According to Morgan Stanley, the prior rating for Lithia Motors Inc (NYSE:LAD) was changed from Equal-Weight to Underweight. Lithia Motors earned $5.46 in the fourth quarter, compared to $2.95 in the year-ago quarter. The current stock performance of Lithia Motors shows a 52-week-high of $392.60 and a 52-week-low of $55.74. Moreover, at the end of the last trading period, the closing price was at $390.85.
- For Virgin Galactic Holdings Inc (NYSE:SPCE), UBS downgraded the previous rating of Buy to Neutral. In the third quarter, Virgin Galactic Hldgs showed an EPS of $0.34, compared to $0.20 from the year-ago quarter. The current stock performance of Virgin Galactic Hldgs shows a 52-week-high of $62.80 and a 52-week-low of $9.06. Moreover, at the end of the last trading period, the closing price was at $56.72.
- According to JP Morgan, the prior rating for Akamai Technologies Inc (NASDAQ:AKAM) was changed from Overweight to Neutral. In the fourth quarter, Akamai Technologies showed an EPS of $1.33, compared to $1.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $124.91 and a 52-week-low of $75.18. Akamai Technologies closed at $117.97 at the end of the last trading period.
- For Leggett & Platt Inc (NYSE:LEG), Raymond James downgraded the previous rating of Strong Buy to Outperform. Leggett & Platt earned $0.76 in the fourth quarter, compared to $0.68 in the year-ago quarter. At the moment, the stock has a 52-week-high of $46.23 and a 52-week-low of $22.03. Leggett & Platt closed at $43.02 at the end of the last trading period.
See all analyst ratings downgrades.
Initiations
- With a Hold rating, Berenberg initiated coverage on Leslies Inc (NASDAQ:LESL). The price target seems to have been set at $27.00 for Leslies. Interestingly, in the first quarter, Leslies's EPS was $0.06. The current stock performance of Leslies shows a 52-week-high of $32.84 and a 52-week-low of $19.15. Moreover, at the end of the last trading period, the closing price was at $26.96.
- With an Overweight rating, Piper Sandler initiated coverage on Catalyst Biosciences Inc (NASDAQ:CBIO). The price target seems to have been set at $15.00 for Catalyst Biosciences. For the third quarter, Catalyst Biosciences had an EPS of $0.73, compared to year-ago quarter EPS of $1.06. At the moment, the stock has a 52-week-high of $8.94 and a 52-week-low of $3.43. Catalyst Biosciences closed at $6.63 at the end of the last trading period.
- Wedbush initiated coverage on Playtika Holding Corp (NASDAQ:PLTK) with an Outperform rating. The price target for Playtika Holding is set to $42.00. The stock has a 52-week-high of $36.06 and a 52-week-low of $28.51. At the end of the last trading period, Playtika Holding closed at $34.28.
- With a Buy rating, HC Wainwright & Co. initiated coverage on ALX Oncology Holdings Inc (NASDAQ:ALXO). The price target seems to have been set at $100.00 for ALX Oncology Holdings. In the third quarter, ALX Oncology Holdings earned $0.31. The stock has a 52-week-high of $117.45 and a 52-week-low of $29.06. At the end of the last trading period, ALX Oncology Holdings closed at $82.18.
- Needham initiated coverage on Open Lending Corp (NASDAQ:LPRO) with a Buy rating. The price target for Open Lending is set to $50.00. In the third quarter, Open Lending showed an EPS of $0.62, compared to $1.25 from the year-ago quarter. The current stock performance of Open Lending shows a 52-week-high of $42.56 and a 52-week-low of $12.70. Moreover, at the end of the last trading period, the closing price was at $40.74.
See all analyst ratings initiations.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.